Twelfth Annual AACR International Conference on Frontiers in Cancer Prevention Re

第十二届 AACR 癌症预防前沿国际会议

• 批准号: 8652143
• 负责人: Margaret Foti
• 金额: $ 3万
• 依托单位: AMERICAN ASSOCIATION FOR CANCER RESEARCH
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-09-27 至 2014-09-26
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8652143
• 关键词: Advocate; American Association of Cancer Research; Attention; Awareness; Basic Science; Behavioral; Carcinogens; Clinical; Collaborations; Colonoscopy; Data; Disease; Early Diagnosis; Early treatment; Education; Effectiveness; Epidemiology; Event; Exercise; Exposure to; Fostering; HBV Vaccination; Health Professional; Hepatitis B Virus; Human; Human Papillomavirus; Incidence; Individual; Information Technology; International; Intervention; Learning; Lesion; Life Style; Mainstreaming; Malignant Neoplasms; Maryland; Molecular; Patients; Physicians; Polypectomy; Population; Premalignant; Prevention; Prevention Research; Prevention strategy; Primary Prevention; Process; Public Health; Recurrence; Research; Research Personnel; Research Technics; Resort; Risk; Scientific Advances and Accomplishments; Scientist; Second Primary Cancers; Secondary Prevention; Series; Specific qualifier value; Survivors; Tobacco; Tobacco use; Translating; Translations; cancer prevention; carcinogenesis; career; clinical application; frontier; interdisciplinary collaboration; interest; lectures; meetings; mortality; posters; prevent; public health relevance; screening; skills; symposium; tertiary prevention; vaccine development

DESCRIPTION (provided by applicant): The Twelfth Annual International Conference on Frontiers in Cancer Prevention Research will take place October 27-30, 2013, at the Gaylord National Resort and Conference Center in National Harbor, Maryland. The AACR has long been a supporter of cancer prevention research aimed at preventing cancer through lifestyle changes and early detection and treatment. This annual AACR conference series debuted in 2002 and remains the pre-eminent cancer prevention meeting in the world, a place where physicians, scientists, patients, and survivor advocates learn about the latest translational discoveries from the leading basic, clinical, epidemiologic, and behavioral scientists in the field. The conference fosters interdisciplinary collaborations, accelerates progression in the field of prevention research, and promotes awareness of the vital importance and of cancer prevention in reducing cancer incidence and mortality. This year's conference theme, "Accelerating Discovery, Translation, and Application," will put the spotlight on the power of prevention. Scientific advances are transforming the field of cancer prevention by providing us with the information and technology needed to understand the molecular underpinnings of carcinogenesis in humans and to identify and intervene in disease processes with unprecedented accuracy and effectiveness. By accelerating new discoveries and translating our understanding of the basic science into clinical application, benefits are being seen at the public health level. Several step within carcinogenic initiation and progression are targets for cancer prevention. Primary prevention is the avoidance of exposure to carcinogens or the carcinogenic process and may be directed at the broad population of individuals who show no sign of premalignancy. Exercise and avoidance of tobacco are examples of this type of intervention. And one of the most successful primary prevention strategies is the development of vaccines such as those for HBV and HPV. Secondary prevention efforts are receiving attention and include screening and early detection, which are generally directed toward a more specified risk population. Examples of this type of prevention include colonoscopy and polypectomy. Studies have found that premalignant lesions may be more common than previously realized and it will be crucial to understand who some premalignant lesions progress to cancer and others do not. Finally, tertiary prevention is aimed at preventing recurrence or second cancers.

描述（由申请人提供）：第十二届癌症预防研究前沿国际会议将于 2013 年 10 月 27 日至 30 日在马里兰州国家港的盖洛德国家度假村和会议中心举行。 AACR 长期以来一直支持癌症预防研究，旨在通过改变生活方式以及早期检测和治疗来预防癌症。这一年度 AACR 系列会议于 2002 年首次举办，至今仍是世界上最杰出的癌症预防会议，医生、科学家、患者和幸存者倡导者在这里可以了解领先的基础、临床、流行病学和行为学领域的最新转化发现。该领域的科学家。会议促进跨学科合作，加速预防研究领域的进展，并提高人们对癌症预防在降低癌症发病率和死亡率方面的重要性的认识。今年的会议主题是“加速发现、转化和应用”，将重点关注预防的力量。科学进步正在改变癌症预防领域，为我们提供了了解人类致癌的分子基础以及以前所未有的准确性和有效性识别和干预疾病过程所需的信息和技术。通过加速新发现并将我们对基础科学的理解转化为临床应用，公共卫生层面的益处正在显现。致癌起始和进展的几个步骤是癌症预防的目标。一级预防是避免接触致癌物或致癌过程，可针对没有癌前迹象的广大人群。锻炼和避免吸烟是此类干预的例子。最成功的一级预防策略之一是开发乙肝病毒和 HPV 等疫苗。二级预防工作正在受到关注，包括筛查和早期发现，这些工作通常针对更具体的风险人群。此类预防的例子包括结肠镜检查和息肉切除术。研究发现，癌前病变可能比之前意识到的更为常见，了解哪些癌前病变会发展为癌症而哪些不会发展为癌症至关重要。最后，三级预防旨在预防复发或继发癌症。